We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 3.99 | 3.11% | 132.3001 | 130.13 | 127.50 | 127.80 | 5,217,386 | 00:58:36 |
From May 2019 to May 2024
"ADR Shares End Lower; Novo Nordisk Shares Trade Actively" on Tuesday at 5:29 p.m. EDT incorrectly said Novo Nordisk received a favorable view from a U.S. Food and Drug Administration advisory committee on its diabetes drug Saxenda. Rather, documents released ahead of the FDA Advisory Committee review suggested Saxenda is effective for weight loss.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
